市場調査レポート
商品コード
1451507
タンパク質検出および定量化市場レポート:製品、技術、用途、エンドユーザー、地域別、2024-2032Protein Detection & Quantification Market Report by Product, Technology, Application, End User, and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
タンパク質検出および定量化市場レポート:製品、技術、用途、エンドユーザー、地域別、2024-2032 |
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2~3営業日
|
世界のタンパク質検出および定量化市場規模は、2023年に28億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに56億米ドルに達し、2024年から2032年の間に7.8%の成長率(CAGR)を示すと予測しています。同市場は、個別化医療が重視されるようになったこと、タンパク質の機能、相互作用、翻訳後修飾に関する新たな知見を見出すプロテオミクス研究のニーズが高まっていること、高感度、高スループット、自動化対応のアッセイや技術に対する需要が高まっていることなどが背景にあり、着実に成長しています。
市場の成長と規模:同市場は、個別化医療、医薬品開発、診断の重視の高まりに牽引され、緩やかな成長を遂げています。また、製薬業界やバイオテクノロジー業界の隆盛が市場の成長を後押ししています。
技術の進歩:質量分析計やイムノアッセイなどのプロテオミクス技術における継続的な技術革新により、より正確で効率的なタンパク質の検出と定量が可能になっています。
産業用途:タンパク質の検出と定量は、医薬品、バイオテクノロジー、臨床診断、学術研究など、さまざまな産業用途で不可欠であり、創薬、バイオマーカー同定、疾患診断に利用されています。
地理的動向:北米はライフサイエンス研究のためのインフラが確立されているため、市場をリードしています。しかし、アジア太平洋地域は、研究および臨床アプリケーションの両方におけるタンパク質分析ツールに対する需要の高まりにより、急成長市場として浮上しています。
競合情勢:市場の主要企業は、いくつかの戦略的イニシアティブに積極的に取り組んでいます。これには、タンパク質検出法の感度と特異性を高めるためのアッセイキット、試薬、機器の継続的な技術革新が含まれます。
課題と機会:同市場は、サンプルのばらつきや標準化されたプロトコルの必要性といった課題に直面する一方で、臨床診断におけるアプリケーションの拡大やポイントオブケア(POC)検査の市場開拓による機会にも遭遇しています。
将来の展望タンパク質検出および定量化市場の将来は、技術の進歩と研究ニーズの増加により、有望視されています。さらに、新興市場への進出と継続的な技術革新が市場の成長を促進すると予想されます。
個別化医療への需要の高まり
個別化医療が重視されるようになり、市場の見通しは良好です。ヘルスケア産業がより個別化された治療戦略へとシフトするにつれて、正確で特異的なタンパク質分析の必要性が最も重要になってきています。タンパク質の定量は、患者固有の遺伝的・分子的プロファイルに従って調整された治療決定の指針となるバイオマーカーの同定において重要な役割を果たしています。これは治療効果を高めるだけでなく、副作用を最小限に抑えることにもつながります。さらに、腫瘍学では、タンパク質の定量は、特定のがんサブタイプを特定し、標的治療に対する反応を予測するのに役立ちます。個別化医療が普及するにつれ、精密なタンパク質検出ツールやアッセイに対する需要が世界中で高まっています。
医薬品開発とバイオテクノロジー研究の増加
医薬品とバイオテクノロジーの分野では、創薬、開発、生産プロセスを通じて正確なタンパク質分析に依存しています。タンパク質は創薬ターゲットの同定、バリデーション、リード化合物の最適化に不可欠です。正確な定量により、医薬品化合物の有効性と安全性が保証されます。さらに、バイオテクノロジー企業は、モノクローナル抗体や酵素などのタンパク質ベースの治療薬を設計し最適化するために、タンパク質の定量を利用しています。新薬や生物製剤の開発に伴い、高度なタンパク質検出および定量化法の需要が高まっています。このような要因がこの分野の技術革新を促し、より高感度、高スループット、自動化に対応したアッセイや技術の開発につながり、市場の成長に寄与しています。
疾患バイオマーカー同定への重点の高まり
疾病の早期発見とバイオマーカー同定への重点の高まりが、市場の成長を促しています。がん、心血管障害、神経疾患など、さまざまな疾患に関連する特定のタンパク質を同定することは、早期診断とモニタリングに不可欠です。タンパク質バイオマーカーは、疾患の存在、進行、治療に対する反応を示す指標となります。そのため、高感度で特異的なタンパク質定量技術が求められています。臨床診断では、タンパク質定量は診断アッセイの開発をサポートし、ヘルスケアの専門家が病気を初期段階で発見できるようにすることで、患者の予後を改善します。さらに、製薬会社は、臨床試験で患者を層別化し、治療効果を評価するために、医薬品開発中のバイオマーカーに依存しています。
プロテオミクス研究のニーズの高まり
プロテオミクス研究のニーズの高まりが市場の成長を後押ししています。プロテオミクスは、生物学的システムにおけるタンパク質の総体に関する研究であり、複雑な生物学的プロセス、疾患、医薬品開発の理解において重要性を増しています。研究者や科学者はプロテオミクスを利用して、タンパク質の機能、相互作用、翻訳後修飾に関する新たな洞察を明らかにしています。このような目的を達成するためには、正確でハイスループットなタンパク質の検出・定量法が不可欠です。がん生物学、神経科学、免疫学などの分野でプロテオミクスの応用が拡大するにつれ、タンパク質を正確に測定・分析できる高度なツールや技術に対する需要が高まっています。この動向は、市場における絶え間ない技術革新の原動力となっており、プロテオミクス研究をサポートする、より洗練された高感度アッセイ、機器、ソフトウェアの開発につながっています。
The global protein detection & quantification market size reached US$ 2.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.6 Billion by 2032, exhibiting a growth rate (CAGR) of 7.8% during 2024-2032. The market is experiencing steady growth driven by the increasing emphasis on personalized medicine, rising need for proteomics research to uncover novel insights into protein functions, interactions, and post-translational modifications and the escalating demand for more sensitive, high-throughput, and automation-compatible assays and technologies.
Market Growth and Size: The market is witnessing moderate growth, driven by the increasing emphasis on personalized medicine, drug development, and diagnostics. Additionally, the thriving pharmaceutical and biotechnology industries are bolstering the growth of the market.
Technological Advancements: Ongoing innovations in proteomics techniques, such as mass spectrometry and immunoassays, are enabling more precise and efficient protein detection and quantification.
Industry Applications: Protein detection and quantification is vital in various industrial applications, including pharmaceuticals, biotechnology, clinical diagnostics, and academic research, which rely on it for drug discovery, biomarker identification, and disease diagnosis.
Geographical Trends: North America leads the market on account of its well-established infrastructure for life sciences research. However, Asia Pacific is emerging as a fast-growing market, driven by the growing demand for protein analysis tools in both research and clinical applications.
Competitive Landscape: Key players in the market are actively engaged in several strategic initiatives. These include continuous innovations in assay kits, reagents, and instruments to enhance sensitivity and specificity in protein detection methods.
Challenges and Opportunities: While the market faces challenges, such as sample variability and the need for standardized protocols, it also encounters opportunities due to expanding applications in clinical diagnostics and the development of point-of-care (POC) testing.
Future Outlook: The future of the protein detection & quantification market looks promising, with advancements in technology and increasing research needs. Moreover, expansion into emerging markets and continued innovation is expected to propel the growth of the market.
Increasing demand for personalized medicine
The growing emphasis on personalized medicine is offering a favorable market outlook. As the healthcare industry shifts towards more individualized treatment strategies, the need for accurate and specific protein analysis is becoming paramount. Protein quantification plays a crucial role in identifying biomarkers that guide treatment decisions tailored as per the unique genetic and molecular profile of patients. This not only enhances the effectiveness of therapies but also minimizes adverse effects. Additionally, in oncology, protein quantification aids in identifying specific cancer subtypes and predicting their response to targeted therapies. As personalized medicine is gaining traction, the demand for precise protein detection tools and assays is rising around the world.
Rise in drug development and biotechnology research
Pharmaceutical and biotechnology sectors rely on accurate protein analysis throughout drug discovery, development, and production processes. Proteins are essential in drug target identification, validation, and lead optimization. Precise quantification ensures the efficacy and safety of pharmaceutical compounds. Moreover, biotechnology companies utilize protein quantification to engineer and optimize protein-based therapeutics, such as monoclonal antibodies and enzymes. With the development of novel drugs and biologics, the demand for advanced protein detection and quantification methods is increasing. This factor drives innovation in the field, leading to the development of more sensitive, high-throughput, and automation-compatible assays and technologies, thereby contributing to the growth of the market.
Increasing emphasis on disease biomarker identification
The rising emphasis on early disease detection and biomarker identification is impelling the growth of the market. Identifying specific proteins associated with various diseases, including cancer, cardiovascular disorders, and neurological conditions, is crucial for early diagnosis and monitoring. Protein biomarkers serve as indicators of disease presence, progression, and response to treatment. This, in turn, is catalyzing the demand for highly sensitive and specific protein quantification techniques. In clinical diagnostics, protein quantification supports the development of diagnostic assays that enable healthcare professionals to detect diseases at their earliest stages, improving patient outcomes. Furthermore, pharmaceutical companies rely on biomarkers during drug development to stratify patients for clinical trials and assess treatment effectiveness.
Growing need for proteomics research
The increasing need for proteomics research is strengthening the growth of the market. Proteomics, the study of the entire complement of proteins in a biological system, is gaining prominence in understanding complex biological processes, diseases, and drug development. Researchers and scientists are using proteomics to uncover novel insights into protein functions, interactions, and post-translational modifications. To achieve these objectives, precise and high-throughput protein detection and quantification methods are indispensable. As proteomics is expanding its applications in fields, such as cancer biology, neuroscience, and immunology, there is a growing demand for advanced tools and techniques that can accurately measure and analyze proteins. This trend is driving continuous innovations in the market, leading to the development of more sophisticated and sensitive assays, instruments, and software to support proteomics research endeavors.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, technology, application, and end user.
Kits and Reagents/Consumables
Instruments
Services
Kits and reagents/consumables account for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the product. This includes kits and reagents/consumables, instruments, and services. According to the report, kits and reagents/consumables represent the largest segment.
Kits and reagents/consumables include a wide range of essential components, such as antibodies, assay kits, and buffers, required for protein analysis. Researchers and laboratories rely on these products for their protein detection assays, Western blotting, enzyme-linked immunosorbent assays (ELISA), and other protein quantification techniques. The availability of high-quality, application-specific reagents and kits simplifies the workflow and ensures accurate results.
The instruments segment encompasses various analytical tools and equipment used for protein detection and quantification, including mass spectrometers, spectrophotometers, and gel electrophoresis systems. These instruments are essential for researchers to carry out precise and advanced protein analysis.
The services segment includes a range of protein-related services, such as protein profiling, quantification, and characterization offered by contract research organizations (CROs), academic institutions, and specialized laboratories. These services cater to clients who may not have the resources or expertise to perform protein analysis in-house.
Colorimetric Assays
Immunological Methods
Chromatography
Mass Spectrometry
Spectroscopy Instruments
Others
Colorimetric assays hold the largest share in the industry
A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes colorimetric assays, immunological methods, chromatography, mass spectrometry, spectroscopy instruments, and others. According to the report, colorimetric assays account for the largest market share.
Colorimetric assays rely on color changes resulting from specific reactions between proteins and reagents. They are preferred for their simplicity, cost-effectiveness, and wide applicability in various research and clinical settings. They are especially valuable for quantifying proteins in high-throughput formats, which is propelling the growth of the market.
Immunological methods, such as Western blotting and immunoprecipitation, are widely used for protein detection and quantification. These techniques leverage the specificity of antibodies to target and measure specific proteins. They offer high sensitivity and are crucial in identifying and verifying protein expression levels, post-translational modifications, and protein-protein interactions in various research fields.
Chromatography-based methods, including high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS), are instrumental in separating and quantifying proteins. They allow for precise protein separation based on size, charge, or affinity, followed by quantification.
Mass spectrometry is a powerful technique for protein identification and quantification. It is instrumental in proteomics studies, allowing researchers to measure proteins with high accuracy and sensitivity. It also provides valuable insights into protein expression, structure, and modifications.
Spectroscopy instruments, including ultraviolet (UV)-visible and infrared spectrometers, are used to analyze proteins based on their interaction with electromagnetic radiation. These instruments are suitable for both qualitative and quantitative protein analysis, providing information on protein concentration, secondary structure, and conformational changes.
Drug Discovery and Development
Clinical Diagnosis
Others
Drug discovery and development represent the leading market segment
The report has provided a detailed breakup and analysis of the market based on the application. This includes drug discovery and development, clinical diagnosis, and others. According to the report, drug discovery and development represent the largest segment as protein analysis plays a pivotal role in identifying and validating potential drug targets, evaluating the effectiveness of drug candidates, and assessing their safety profiles. Precise quantification of proteins involved in disease pathways, as well as the measurement of biomarkers, aids in the discovery of novel therapeutics. Additionally, during the drug development process, protein quantification ensures the quality and consistency of biopharmaceutical products, such as monoclonal antibodies and recombinant proteins.
The clinical diagnosis segment involves the use of protein detection and quantification techniques in medical diagnostics. Protein biomarkers are critical for disease diagnosis, prognosis, and monitoring treatment responses. Clinical laboratories and healthcare settings rely on these methods to detect specific proteins associated with various diseases, including cancer markers, cardiac biomarkers, and infectious disease antigens. Accurate protein quantification is essential for early disease detection, personalized medicine, and patient care.
Academic Research Institutes
Biotechnology and Pharmaceutical Companies
Contract Research Organization
Others
Biotechnology and pharmaceutical companies dominate the market
The report has provided a detailed breakup and analysis of the market based on the end user. This includes academic research institutes, biotechnology and pharmaceutical companies, contract research organization, and others. According to the report, biotechnology and pharmaceutical companies represent the largest segment.
Biotechnology and pharmaceutical companies rely on protein analysis for various purposes, including drug discovery, development, and quality control. Precise quantification of proteins is crucial in target identification, validation, and lead optimization phases of drug development. Additionally, biotech and pharmaceutical companies use protein detection to assess the purity and consistency of biopharmaceutical products, ensuring their safety and efficacy.
Academic research institutes are significant users of protein detection and quantification technologies. These institutions conduct fundamental research across various scientific disciplines, including molecular biology, biochemistry, and cellular biology. Protein analysis is essential in academic laboratories for studying protein functions, interactions, and their role in disease pathways.
Contract research organizations (CROs) offer specialized protein-related services to biotech, pharmaceutical companies, and academic institutions. These services may include protein profiling, quantification, and characterization. CROs play a critical role in supporting research and development (R&D) activities by providing expertise, equipment, and resources for protein analysis.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America leads the market, accounting for the largest protein detection & quantification market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounts for the largest market share due to its well-established infrastructure for life sciences research, a high concentration of biotechnology and pharmaceutical companies, and government and private investments in healthcare and research activities. The United States is a major contributor to the market growth, driven by its leading role in drug discovery and development. Additionally, academic research institutes in the region are focusing on innovations in protein analysis technologies.
The Asia Pacific region is experiencing substantial growth on account of the increasing research and development (R&D) activities, rising investments in life sciences, and the expansion of biotechnology and pharmaceutical industries. Emerging economies like China and India are becoming key players, with a growing demand for protein analysis tools in both research and clinical applications.
Europe is another significant market, characterized by the thriving pharmaceutical and biotechnology sectors, renowned research institutions, and a focus on cutting-edge scientific advancements. Countries like Germany, the United Kingdom, and France have a strong presence in the market, with a growing emphasis on proteomics research.
Latin America is an emerging market, with partnerships with global pharmaceutical companies and academic collaborations. In addition, the growing demand for enhanced healthcare infrastructure is offering a favorable market outlook in the region.
The Middle East and Africa region show potential for growth in the market due to the increasing number of academic institutions. Besides this, rising investments in healthcare facilities by the governing agencies in the region are bolstering the market growth.
Key players in the market are actively engaged in several strategic initiatives. These include continuous innovations in assay kits, reagents, and instruments to enhance sensitivity and specificity in protein detection methods. They are also investing in the development of high-throughput and automation-compatible platforms, catering to the increasing demand for efficient protein analysis. Collaboration with academic and research institutions is fostering research and development (R&D) activities of cutting-edge technologies. Additionally, key players are expanding their global footprint by entering emerging markets in Asia-Pacific and Latin America. Overall, they are committed to advancing protein detection and quantification technologies to meet the evolving needs of the scientific and pharmaceutical communities.
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
Danaher Corporation
General Electric Company
Inanovate Inc.
Merck KGaA
PerkinElmer Inc.
RayBiotech Life Inc.
Shimadzu Corporation
Thermo Fisher Scientific Inc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
April 26, 2023: Agilent Technologies Inc. announced the signing of a Memorandum of Understanding (MOU) with Theragen Bio in South Korea to boost precision oncology through advancing bioinformatic (BI) solutions. Through this partnership agreement, Agilent and Theragen Bio will combine their respective strengths in cancer genomic profiling (CGP) design, engineering knowledge and software expertise to drive localized analysis capabilities and accelerate treatment decisions.
June 30, 2021: Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced a partnership with Seegene, Inc., a global leader in multiplex molecular diagnostics, for the clinical development and commercialization of infectious disease molecular diagnostic products. Through this agreement, Seegene will provide diagnostic tests for use on Bio-Rad's CFX96(TM) Dx Real-Time PCR System for US markets pending clinical development and clearance from The US Food and Drug Administration (FDA).
March 7, 2023: Danaher Corporation, a global science and technology innovator, announced a strategic partnership with the University of Pennsylvania (Penn) focusing on cell therapy innovation. This multi-year partnership aims to develop new technologies that will improve the consistency of clinical outcomes for patients and overcome manufacturing bottlenecks in the delivery of next generation engineered cell products.